How to buy Microbot Medical stock (MBOT)

Microbot Medical is a medical instruments & supplies business based in the US. Microbot Medical shares (MBOT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.97 – a decrease of 2.66% over the previous week. Microbot Medical employs 21 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Microbot Medical stock

Buy Microbot Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Microbot Medical stock price (NASDAQ: MBOT)

Use our graph to track the performance of MBOT stocks over time.

Microbot Medical shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$0.97
52-week range	$0.82 - $2.23
50-day moving average more info button	$0.97
200-day moving average more info button	$1.02
Wall St. target price	$7.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.79

Is it a good time to buy Microbot Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Microbot Medical price performance over time

Historical closes compared with the close of $1.01 from 2024-12-17

1 week (2024-12-12)	1.07%
1 month (2024-11-19)	9.31%
3 months (2024-09-18)	9.14%
6 months (2024-06-18)	-0.98%

1 year (2023-12-19)	-28.37%
2 years (2022-12-19)	-72.25%
3 years (2021-12-17)	5.08
5 years (2019-12-19)	5.79

Microbot Medical financials

Gross profit TTM	$0
Return on assets TTM	-64.88%
Return on equity TTM	-134.46%
Profit margin	0%
Book value	$0.38
Market Capitalization more info button	$17.3 million

TTM: trailing 12 months

Microbot Medical share dividends

We're not expecting Microbot Medical to pay a dividend over the next 12 months.

Have Microbot Medical's shares ever split?

Microbot Medical's shares were split on a 1:15 basis on 4 September 2018 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Microbot Medical shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Microbot Medical shares which in turn could have impacted Microbot Medical's share price.

Microbot Medical share price volatility

Over the last 12 months, Microbot Medical's shares have ranged in value from as little as $0.82 up to $2.23. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Microbot Medical's is 1.628. This would suggest that Microbot Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Microbot Medical overview

Microbot Medical Inc. , a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Frequently asked questions

What percentage of Microbot Medical is owned by insiders or institutions?
Currently 1.429% of Microbot Medical shares are held by insiders and 7.459% by institutions. How many people work for Microbot Medical?
Latest data suggests 21 work at Microbot Medical. When does the fiscal year end for Microbot Medical?
Microbot Medical's fiscal year ends in December. Where is Microbot Medical based?
Microbot Medical's address is: 288 Grove Street, Braintree, MA, United States, 02184 What is Microbot Medical's ISIN number?
Microbot Medical's international securities identification number is: US59503A2042 What is Microbot Medical's CUSIP number?
Microbot Medical's Committee on Uniform Securities Identification Procedures number is: 232923102